Track the ノイルイミューン・バイオテック株式会社 share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares trade on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ノイルイミューン・バイオテック株式会社 has recorded 11 public disclosures. Market capitalisation: €8,802.9bn. The latest transaction was reported on 31 July 2024 (Holding update). Among the most active insiders: TSURUKAME CO.,LTD. All data is accessible without an account.
Analysts rate ノイルイミューン・バイオテック株式会社 Buy (bullish), based on 16 analysts. Average price target: JP¥6,375.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Noil Immune Biotech Co., Ltd. is a company focused on the health and pharmaceutical sector, specializing in the development of biopharmaceutical solutions. It is listed on the XTKS market.